(Q37823204)

23 August 2017

1 reference

title

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer (English)

1 reference

adaptive radiation therapy

23 August 2017

main subject

0 references

1 reference

0 references

Robert G Bristow

0 references

Padraig Warde

0 references

Theodorus H. van der Kwast

object named as

Theodorus H van der Kwast

0 references

John Thoms

1 reference

23 August 2017

Jayant S Goda

series ordinal

1 reference

23 August 2017

Alexender R Zlotta

series ordinal

1 reference

23 August 2017

Neil E Fleshner

series ordinal

1 reference

23 August 2017

language of work or name

English

0 references

publication date

21 December 2010

1 reference

Nature Reviews Clinical Oncology

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

107-113

1 reference

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

The radiobiology of prostate cancer including new aspects of fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Urine analysis and protein networking identify met as a marker of metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Clinical Application of High-Dose, Image-Guided Intensity-Modulated Radiotherapy in High-Risk Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

EAU guidelines on prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Extended Experience With Radical Prostatectomy for Clinical Stage T3 Prostate Cancer: Outcome and Contemporary Morbidity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Adjuvant Radiotherapy After Surgery for Pathologically Advanced Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Radical prostatectomy after radiotherapy for prostatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

A phase I trial of pre-operative radiotherapy for prostate cancer: Clinical and translational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Improved survival with preoperative radiotherapy in resectable rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

The TME Trial After a Median Follow-up of 6 Years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Response to “Intraoperative Radiotherapy During Radical Prostatectomy for Locally Advanced Prostate Cancer: Technical and Dosimetric Aspects” (Int J Radiat Oncol Biol Phys 2009; in press)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.207

Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21178999

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21178999

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2010.207

1 reference

23 August 2017

1 reference